Not a cream, collagen matrix. It's a wound dressing, quite a few already out there. Assuming this goes as planned, Avita will pay $2M end of this year, $3M a year later. Also in for R&D expenses, undisclosed. No price point discussed.
Another expensive distribution deal with products in already crowded markets with possible payback off in the future. Our European partner became Recell's distributor for next to nothing. Maybe JC needs to get some lessons from that guy.
And before you correct me Salty, JC himself described the Permeaderm market as crowded near the end of the Q call or the webinar, don't remember which. Went back and listened for a 3rd time.
Not a cream, collagen matrix. It's a wound dressing, quite a few...
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.60 |
Change
0.020(0.78%) |
Mkt cap ! $180.1M | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.63 | $2.56 | $229.1K | 88.76K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $2.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.60 | 18050 | 2 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |